A Phase 1 Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer.
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2013
At a glance
- Drugs Axitinib (Primary) ; Capecitabine; Cisplatin
- Indications Gastric cancer
- Focus Adverse reactions; Pharmacogenomic
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Apr 2012 Planned end date changed from 1 Mar 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 23 Feb 2012 Actual patients number is 22 as reported by ClinicalTrials.gov.